New hepatitis C virus genotype 1 subtype naturally harbouring resistance-associated mutations to NS5A inhibitors

References

1. Choo QL, Richman KH, Han JH, Berger K, Lee C et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 1991; 88:2451–2455 [View Article][PubMed]
   [Google Scholar]
2. Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM et al. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology 2014; 59:318–327 [View Article][PubMed]
   [Google Scholar]
3. Li C, Lu L, Murphy DG, Negro F, Okamoto H. Origin of hepatitis C virus genotype 3 in Africa as estimated through an evolutionary analysis of the full-length genomes of nine subtypes, including the newly sequenced 3d and 3e. J Gen Virol 2014; 95:1677–1688 [View Article][PubMed]
   [Google Scholar]
4. Lu L, Xu Y, Yuan J, Li C, Murphy DG. The full-length genome sequences of nine HCV genotype 4 variants representing a new subtype 4s and eight unclassified lineages. Virology 2015; 482:111–116 [View Article][PubMed]
   [Google Scholar]
5. Lu L, Wu T, Xiong L, Li C, Nguyen MH et al. Analysis of HCV-6 isolates among Asian-born immigrants in North America reveals their high genetic diversity and a new subtype. Virology 2016; 492:25–31 [View Article][PubMed]
   [Google Scholar]
6. Martell M, Esteban JI, Quer J, Genescà J, Weiner A et al. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 1992; 66:3225–3229[PubMed]
   [Google Scholar]
7. Vermehren J, Sarrazin C. The role of resistance in HCV treatment. Best Pract Res Clin Gastroenterol 2012; 26:487–503 [View Article][PubMed]
   [Google Scholar]
8. Bracho MA, Carrillo-Cruz FY, Ortega E, Moya A, González-Candelas F. A new subtype of hepatitis C virus genotype 1: complete genome and phylogenetic relationships of an Equatorial Guinea isolate. J Gen Virol 2006; 87:1697–1702 [View Article][PubMed]
   [Google Scholar]
9. Bacon BR, Gordon SC, Lawitz E, Marcellin P, Vierling JM et al. Boceprevir for previously treated chronic HCV genotype 1 infection. N Engl J Med 2011; 364:1207–1217 [View Article][PubMed]
   [Google Scholar]
10. Poordad F, McCone J, Bacon BR, Bruno S, Manns MP et al. Boceprevir for untreated chronic HCV genotype 1 infection. N Engl J Med 2011; 364:1195–1206 [View Article][PubMed]
    [Google Scholar]
11. Poordad F, Hezode C, Trinh R, Kowdley KV, Zeuzem S et al. ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis. N Engl J Med 2014; 370:1973–1982 [View Article][PubMed]
    [Google Scholar]
12. Sarrazin C. The importance of resistance to direct antiviral drugs in HCV infection in clinical practice. J Hepatol 2016; 64:486–504 [View Article][PubMed]
    [Google Scholar]
13. Zeuzem S, Soriano V, Asselah T, Bronowicki JP, Lohse AW et al. Faldaprevir and deleobuvir for HCV genotype 1 infection. N Engl J Med 2013; 369:630–639 [View Article][PubMed]
    [Google Scholar]
14. Doyle JS, Hellard ME, Thompson AJ. The role of viral and host genetics in natural history and treatment of chronic HCV infection. Best Pract Res Clin Gastroenterol 2012; 26:413–427 [View Article][PubMed]
    [Google Scholar]
15. Lam AM, Espiritu C, Bansal S, Micolochick Steuer HM, Niu C et al. Genotype and subtype profiling of PSI-7977 as a nucleotide inhibitor of hepatitis C virus. Antimicrob Agents Chemother 2012; 56:3359–3368 [View Article][PubMed]
    [Google Scholar]
16. Mauss S, Berg T, Rockstroh J, Sarrazin C, Wedemeyer H et al. Short guide to hepatitis C. In Mauss S, Berg T, Rockstroh J, Sarrazin C, Wedemeyer H et al. (editors) The Flying Publisher Group The Flying Publisher Guide; 2012
    [Google Scholar]
17. Quer J, Gregori J, Rodríguez-Frias F, Buti M, Madejon A et al. High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods. J Clin Microbiol 2015; 53:219–226 [View Article][PubMed]
    [Google Scholar]
18. Rodriguez-Frias F, Nieto-Aponte L, Gregori J, Garcia-Cehic D, Casillas R et al. High HCV subtype heterogeneity in a chronically infected general population revealed by high-resolution hepatitis C virus subtyping. Clin Microbiol Infect 2017; 23:775.e1–775.e6 [View Article][PubMed]
    [Google Scholar]
19. Kuiken C, Combet C, Bukh J, Shin-I T, Deleage G et al. A comprehensive system for consistent numbering of HCV sequences, proteins and epitopes. Hepatology 2006; 44:1355–1361 [View Article][PubMed]
    [Google Scholar]
20. Lontok E, Harrington P, Howe A, Kieffer T, Lennerstrand J et al. Hepatitis C virus drug resistance-associated substitutions: State of the art summary. Hepatology 2015; 62:1623–1632 [View Article][PubMed]
    [Google Scholar]
21. R: A language and environment for statistical computing [computer program] Vienna, Austria: R Foundation for Statistical Computing; 2016
    [Google Scholar]
22. Edgar RC. MUSCLE: a multiple sequence alignment method with reduced time and space complexity. BMC Bioinformatics 2004; 5:113 [View Article][PubMed]
    [Google Scholar]